Bayern Munich Stand Firm Behind Musiala Amid Health Concerns

Bayern Munich have closed the door on signing cover for Jamal Musiala this summer, choosing solidarity over short-term solutions after the playmaker’s shock medical diagnosis.

According to German journalist Florian Plettenberg of Sky, the club hierarchy remain fully behind Musiala and see no need to move in the market to replace him. Internally, the message is clear: he is still central to their plans, and the squad already carries enough firepower in his position.

Lennart Karl, Ismaël Saibari and Serge Gnabry are viewed as the main options to step into the attacking midfield role when needed, giving the coaching staff tactical flexibility without forcing a rethink of the transfer strategy.

Musiala’s situation has cast a different kind of spotlight on Bayern’s pre-season. The 21-year-old only recently fought his way back after a brutal injury run: a fractured fibula and a dislocated ankle kept him out for around six months. He returned in the second half of last season, then went on to join Germany at the 2026 World Cup, a comeback that underlined both his talent and resilience.

Now a new challenge has arrived.

On Wednesday, Musiala revealed that he is under medical monitoring after suffering two unexplained falls on the pitch within three days. Doctors have diagnosed what he described as temporary and treatable neurological disorders, and the Germany international stressed that there are no serious health risks.

The incidents were as alarming as they were sudden. In Bayern’s 3-1 friendly win over Leipzig last Saturday, Musiala had just come on as a substitute and scored the third goal when he collapsed without any contact. He left the field, the celebrations quickly replaced by concern.

Then it happened again.

During Bayern’s 4-2 victory over Heidenheim on Tuesday, Musiala once more went down without a challenge, prompting immediate medical attention and raising urgent questions about his condition.

Those questions have shaped the club’s stance. Instead of reacting with a big-name signing or scrambling for a like-for-like replacement, Bayern are choosing stability and trust in the player they consider one of their cornerstones.

They believe the diagnosis, they believe the treatment plan, and they believe Musiala will be back dictating games in the final third.

The squad depth gives them the luxury of patience. The real test now is not just how quickly Musiala returns, but how Bayern manage a season in which football and health are suddenly, and unavoidably, intertwined.